Model‐based assessment of the benefits and risks of recombinant tissue plasminogen activator treatment in acute ischaemic stroke-Reference-Cited by-同舟云学术

Model‐based assessment of the benefits and risks of recombinant tissue plasminogen activator treatment in acute ischaemic stroke

Published:2018-08-21 Issue:11 Volume:84 Page:2586-2599
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Guk Jinju¹²,Chae Dongwoo¹²,Son Hankil¹,Yoo Joonsang³,Heo Ji Hoe⁴,Park Kyungsoo¹^ORCID

Affiliation:

1. Department of PharmacologyYonsei University College of Medicine Seoul South Korea

2. Brain Korea 21 plus Project for Medical ScienceYonsei University Seoul South Korea

3. Department of NeurologyKeimyung University College of Medicine Daegu South Korea

4. Department of NeurologyYonsei University College of Medicine Seoul South Korea

Funder

Ministry of Education, Science and Technology

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.13715

Reference37 articles.

1. An Updated Definition of Stroke for the 21st Century

2. Guidelines for the Early Management of Patients With Acute Ischemic Stroke

3. American Association of Neuroscience Nurses.Guide to the care of the patient with ischemic stroke. Reference series for clinical practice. Glenview IL: Author 2004. Available athttps://www.centracare.com/app/files/public/5583/neurohcps-stroke-center-aann-guideline-for-ischemic-stroke.pdf(last accessed 7 August 2018).

4. Clinical Policy: Use of Intravenous tPA for the Management of Acute Ischemic Stroke in the Emergency Department

5. Use of a Global Test for Multiple Outcomes in Stroke Trials With Application to the National Institute of Neurological Disorders and Stroke t-PA Stroke Trial

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sparse item testing of clinical scales in neurology trials to alleviate burden to patients;Journal of Neurology;2024-08-30

2. Item response theory in early phase clinical trials: Utilization of a reference model to analyze the Montgomery‐Åsberg Depression Rating Scale;CPT: Pharmacometrics & Systems Pharmacology;2023-08-10

3. SENP6 induces microglial polarization and neuroinflammation through de-SUMOylation of Annexin-A1 after cerebral ischaemia–reperfusion injury;Cell & Bioscience;2022-07-22

4. Causality assessment between reported fatal cerebral haemorrhage and suspected drugs: developing a new algorithm based on the analysis of the Japanese Adverse Event Report (JADER) database and literature review;European Journal of Clinical Pharmacology;2021-04-07

5. Inhibition of SENP6 restrains cerebral ischemia-reperfusion injury by regulating Annexin-A1 nuclear translocation-associated neuronal apoptosis;Theranostics;2021